new radiopharmaceuticals - international atomic energy agency
Post on 04-Feb-2022
9 Views
Preview:
TRANSCRIPT
2.1 HEPATOBILIARY IMAGING AGENTS
2.2 HEART IMAGING AGENTS
2.3 BRAIN IMAGING AGENTS
2.5 CHEMICAL STUDIES ON DTPA-COMJUGATED MONOCLONAL ANTIBODY OB' HUMAN FIBRINOGEN LABELLED WITH RADIOIMDIUM FOR THROMBOSIS SCINTIGRAPHY
3. NEW COMPOUNDS STUDIED UNDER THE CRP
3.1 HEPATOBILTARY AGENTS
3.2 BRAIN AGENTS
3.3 HEART AGENTS
Appendix I - PREPARATION OF 2-METHOXYISOBUTYLISOCYANIDE AND ITS CUPROUS CHELATE (MIBI)
Appendix II - SYNTHESIS AND EVALUATION OF Tc COMPLEXES OF AROMATIC ISOCYANIDES AS POTENTIAL MYOCARDIAL IMAGING AGENTS
Appendix III - SYNTHESIS AND ISOLATION OF d1-HMPAO
REFERENCE
LIST OF PARTICIPANTS
2.2 HEART IMAGING AGENTS
2.3 BRAIN IMAGING AGENTS
2.5 CHEMICAL STUDIES ON DTPA-COMJUGATED MONOCLONAL ANTIBODY OB' HUMAN FIBRINOGEN LABELLED WITH RADIOIMDIUM FOR THROMBOSIS SCINTIGRAPHY
3. NEW COMPOUNDS STUDIED UNDER THE CRP
3.1 HEPATOBILTARY AGENTS
3.2 BRAIN AGENTS
3.3 HEART AGENTS
Appendix I - PREPARATION OF 2-METHOXYISOBUTYLISOCYANIDE AND ITS CUPROUS CHELATE (MIBI)
Appendix II - SYNTHESIS AND EVALUATION OF Tc COMPLEXES OF AROMATIC ISOCYANIDES AS POTENTIAL MYOCARDIAL IMAGING AGENTS
Appendix III - SYNTHESIS AND ISOLATION OF d1-HMPAO
REFERENCE
LIST OF PARTICIPANTS
top related